NeuroSense Therapeutics Ltd. (NRSN) Deferred Tax Assets, Gross

NeuroSense Therapeutics Ltd. Deferred Tax Assets, Gross

NeuroSense Therapeutics Ltd. (NRSN) had Deferred Tax Assets, Gross of $10.18 million as of 2025-12-31, per its 20-F filed 2026-03-31.

Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsGross · last filed 2026-03-31

• 2025-12-31: Deferred Tax Assets, Gross $10.18M.
• 2024-12-31: Deferred Tax Assets, Gross $7.15M.
• 2023-12-31: Deferred Tax Assets, Gross $4.86M.